South Korea · Delayed Price · Currency is KRW Dong-A Socio Holdings Company Description
Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally.
It offers Bacchus, Benachio, and Tempo; infection management products; imaging equipment, such as FX-V1 and CLS-S7 for surgery and diagnosis; and MEDIFLIX, a medical knowledge-sharing platform.
The company provides business management services; CMO services, including pre-clinical study, clinical trial, and commercial production of antibodies and recombinant proteins; maintenance, repair, and operation; quarantine; and military logistics services; and packaging and parcel delivery services.
In addition, it offers mineral water under the Gayasan Cheonnyeonsu brand; POCARI SWEAT; Narangd cider; Oronamin C; Oran-C bio-PET; and STP2104, an mRNA based COVID-19 vaccine, which is in phase I clinical trial.
Further, the company engages in the construction of industrial facilities, such as bio, pharmaceutical, food, logistics warehouses, education/research facilities, work/sales facilities, and public facilities; provides design, maintenance, and asset development services.
Additionally, it provides IT systems development and maintenance. The company was founded in 1932 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1932 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Min-Young Kim |
Contact Details
Address: 64, Cheonho-daero Seoul South Korea | |
| Phone | 82 2 920 8114 |
Stock Details
| Ticker Symbol | 000640 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7000640003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Min-Young Kim | Chief Executive Officer and Executive Director |
| Seung Hyun Ko | Executive Director, Chief Financial Officer and Head of Management Support Office |
| Hyun-Min Lee | Executive Director and Head of Business Planning Office |